Klinisk anvendelse af antimüllersk hormon i fertilitetsbehandling

TY - JOUR

T1 - Klinisk anvendelse af antimüllersk hormon i fertilitetsbehandling

AU - Pilsgaard, Fie

AU - Grynnerup, Anna Garcia-Alix

AU - Løssl, Kristine

AU - Pinborg, Anja

PY - 2017

Y1 - 2017

N2 - The need for fertility treatment in Denmark is increasing, one of the main causes being postponed parenthood. Ovarian reserve is determined by the anti-Müllerian hormone (AMH) level and by antral follicle count. Both tests can predict the ovarian response to gonadotropin treatment prior to in vitro fertilization (IVF) and are used to individualize ovarian stimulation to achieve an appropriate number of follicles and to avoid ovarian hyperstimulation. A new assay detects low values of AMH and may predict who will benefit from IVF, and who should be referred directly to oocyte donation.

AB - The need for fertility treatment in Denmark is increasing, one of the main causes being postponed parenthood. Ovarian reserve is determined by the anti-Müllerian hormone (AMH) level and by antral follicle count. Both tests can predict the ovarian response to gonadotropin treatment prior to in vitro fertilization (IVF) and are used to individualize ovarian stimulation to achieve an appropriate number of follicles and to avoid ovarian hyperstimulation. A new assay detects low values of AMH and may predict who will benefit from IVF, and who should be referred directly to oocyte donation.

M3 - Tidsskriftartikel

C2 - 28869028

SN - 0041-5782

VL - 179

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 32

M1 - V02170099

ER -